It is a pharma private limited company based in Delhi, Delhi, India, established in 2020.
2020 | Delhi, Delhi, India | ActiveAdmed Pharma Private Limited, a active private limited company, was established on 30 October 2020 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36900DL2020PTC372472. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 88 professional, Its leadership includes Surinder Kumar Sharma (Director), Ashutosh Goel (Director), Mayank Goel (Director). Past directors included Surinder Kumar Sharma. It holds ₹17.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-4 Upper Ground Floor Pushpanjli Enclave, Pitampura, Delhi, Delhi, 110034.
U36900DL2020PTC372472
372472
30 October 2020
₹2.50 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Admed Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Kumar Sharma | Director | 15 Jul 2023 | Current |
| Ashutosh Goel | Director | 30 Oct 2020 | Current |
| Mayank Goel | Director | 30 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Admed Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 2.76% increase. The company also saw a slight improvement in profitability, with a 2.3% increase in profit. The company's net worth Soared by an impressive increase of 99.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Admed Pharma had a public holding of 37.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹177,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2022 | Axis Bank Limited | ₹9.70 Cr | Open |
| 25 Feb 2022 | Axis Bank Limited | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Admed Pharma has a workforce of 88 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Admed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admed Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited of Rs. 97.00 M registered on 28 Feb 2022 with Charge ID 100553299 was modified on 09 Dec 2024. was documented.
The activity A charge with Axis Bank Limited of Rs. 80.00 M registered on 25 Feb 2022 with Charge ID 100553290 was modified on 06 Dec 2024. was completed.
Admed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Admed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Surinder Kumar Sharma was appointed as a Director was appointed as a Director on 15 Jul 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 97.00 M with Charge ID 100553299 was registered on 28 Feb 2022. was documented.
The CIN of Admed Pharma Private Limited is U36900DL2020PTC372472.
Admed Pharma Private Limited is headquartered at A-4 Upper Ground Floor Pushpanjli Enclave, Pitampura, Delhi, Delhi, 110034.
Admed Pharma Private Limited was incorporated on 30 October 2020.
The current directors of Admed Pharma Private Limited are
The primary industry of Admed Pharma Private Limited is Manufacturing.
Admed Pharma Private Limited is unlisted.
The authorized capital of Admed Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Admed Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX